Evidence map›Paper›PMID 36454164›Full record

ArticleOmics : a journal of integrative biology2022

The Application of Spearman Partial Correlation for Screening Predictors of Weight Loss in a Multiomics Dataset.

Joel Correa da Rosa, Jose O Aleman, Jason Mohabir, Yupu Liang, Jan L Breslow, Peter R Holt

Open access · greenAbstract read
In one paragraph

Article in Omics : a journal of integrative biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Joel Correa da RosaDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.ORCID 0000-0003-4221-1976
Jose O AlemanDivision of Endocrinology, New York University Langone Health, New York, New York, USA.
Jason MohabirInfectious Disease and Microbe Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Yupu LiangDana Farber Cancer Institute's Data Science Department, Boston, Massachusetts, USA.
Jan L BreslowLaboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, New York, USA.
Peter R HoltLaboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, New York, USA.
Rockefeller University · USBroad Institute · USDana-Farber Cancer Institute · USIcahn School of Medicine at Mount Sinai · USNYU Langone Health · US

Funding

Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
New York Regional Center for Diabetes Translation Research - Translational Intervention Methodology CoreP30DK111022 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI JEFFREY GONZALEZ · 2016 to 2026
$7.8M
NCATS NIH HHS UL1 TR000043NIDDK NIH HHS P30 DK111022
6 · The paper itself

Abstract

Obesity has reached epidemic proportions in the United States, but little is known about the mechanisms of weight gain and weight loss. Integration of omics data is becoming a popular tool to increase understanding in such complex phenotypes. Biomarkers come in abundance, but small sample size remains a serious limitation in clinical trials. In the present study, we developed a strategy to screen predictors from a multiomics, high-dimensional, and longitudinal dataset from a small cohort of 10 women with obesity who were provided an identical very-low calorie diet. Our proposal explores the combinatorial space of potential predictors from transcriptomics, microbiome, metabolome, fecal bile acids, and clinical data with the application of the first-order Spearman partial correlation coefficient. Two statistics are proposed for screening predictors, the partial association score, and the persistent significance. We applied our strategy to predict rates of weight loss in our sample of participants in a hospital metabolic facility. Our method reduced an initial set of 42,000 biomarker candidates to 61 robust predictors. The results show baseline fecal bile acids and regulation in RT-polymerase chain reaction as the most predictive data sources in forecasting the rate of weight-loss. In summary, the present study proposes a strategy based on nonparametric statistics for ranking and screening predictors of weight loss from a multiomics study. The proposed biomarker screening strategy warrants further translational clinical investigation in obesity and other complex clinical phenotypes.

Indexed as

MultiomicsWeight LossBile Acids and SaltsFecesFemaleHumansObesityBile Acids and Saltsmultiomicsnutrition scienceobesitySpearman partial correlationvery-low calorie dietweight loss

Identifiers

PMID36454164
PMCPMC9805879
OpenAlexW4310525842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.